Nanotechnology Now - Press Release: "Nanotechnology: Players, products & prospects to 2018 (Volume II)"

Home > Press > Nanotechnology: Players, products & prospects to 2018 (Volume II)

Abstract:
Bharatbook added a new report on "Nanotechnology: Players, products & prospects to 2018 (Volume II)" which gives in-depth analysis and forecast on the Nanotechnology Market.

Nanotechnology: Players, products & prospects to 2018 (Volume II)

Navi Mumbai | Posted on January 20th, 2011

Nano-enabled Delivery

The true value of nanotechnology lies in its potential to improve the solubility and enhance the efficiency of product delivery. It has been successfully applied to the commercialisation of more than 30 drugs. Regulators have published numerous white papers on the topic and established Task Forces to monitor the progress and application of this technology although there are presently no regulations specific to nanomedicine or nano-enabled medical devices.

As the field of nanotechnology gains momentum and nano-enabled platforms emerge to address the industry's need for therapeutic, bioavailable and less toxic products, this market is expected to grow significantly over the next decade. Proof of concept data with novel compounds is accumulating and new formulations of old chemotherapeutic drugs offer the promise to revolutionise cancer therapies.

The potential of future applications:

Tissue specific delivery - targeting the delivery of small and macro molecules across biological membranes such as the blood brain barrier for CNS drugs; Gene and vaccine delivery - non-viral delivery of genetic materials in nanohydrogels and nanocarriers with a high degree of efficiency and expression; Controlled-release devices - design of new nanoporous, bioerodible membranes; Increased biocompatibility - design of artificial surfaces engineering for medical and dental implants to by-pass unwanted inflammatory response; Improved drug bioavailability and solubility - through the engineering of drugs and reagents by nanostructuring; Applied diagnosis, etiology, prognosis and therapy (ADEPT) technology for the safe targeted delivery of toxic therapeutic drugs.

By 2018, the market could exceed US$13 billion

By 2018 the established nanotechnology product market will be US$10.2 billion. The market will mature as the number of marketed nano-enabled products doubles and second generation nanomedicines begin to emerge. These agents will address areas of high unmet clinical need and result in the formulation of approved and novel drugs which are safer, less toxic and more efficacious than first generation products.

By 2018 these second generation nanomedicines could generate sales of nearly US$2.9 billion and establish nanotechnology as an important tool in the industry's delivery armoury. A range of proprietary delivery platforms will utilise CaP technologies, FluidCrystals, micelles and polymeric nanoparticles to target a number of therapy areas such as CNS disorders, oncology and infectious diseases.

For more information kindly visit:

www.bharatbook.com/detail.asp?id=159011&rt=Nanotechnology-Players-products-prospects-to-2018-Volume-II.html

####

For more information, please click here

Contacts:
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: